Home/Filings/4/0001104659-19-038306
4//SEC Filing

Sard Mark 4

Accession 0001104659-19-038306

CIK 0001264587other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 5:15 PM ET

Size

4.8 KB

Accession

0001104659-19-038306

Insider Transaction Report

Form 4
Period: 2019-06-25
Sard Mark
Director
Transactions
  • Award

    Common Stock

    2019-06-25+15,00051,468 total
Footnotes (2)
  • [F1]The restricted shares will vest according to the following schedule: 5,000 shares on 6/25/2020, 5,000 shares on 6/25/2021 and 5,000 shares on 6/25/2022.
  • [F2]Of the 51,468 shares, 28,645 shares are restricted stock.

Documents

1 file

Issuer

STEMLINE THERAPEUTICS INC

CIK 0001264587

Entity typeother

Related Parties

1
  • filerCIK 0001737651

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:15 PM ET
Size
4.8 KB